Business News/Market/Market Stats/   Dr Reddys Laboratories share price
Mutual Fund Ownership
Ownership as on: Tue, 26 Sep, 2023

Tata India Pharma & Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)65.50
% of AUM9.94%

LIC MF Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)5.05
% of AUM9.75%

Mirae Asset Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)151.89
% of AUM8.38%

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth

NA
Equity
Amount Invested (Cr.)239.80
% of AUM7.55%

Market Live Updates

26 Sep 2023, 01:02:31 PM IST
Dr Reddy share price NSE Live :Dr Reddy closed today at 5468.1, up 0.53% from yesterday's 5439.4
26 Sep 2023, 12:49:22 PM IST
Dr Reddy share price live: Stock Peers
26 Sep 2023, 12:08:40 PM IST
Dr Reddys Laboratories share price live: Today's Price range
26 Sep 2023, 10:02:22 AM IST
Dr Reddy September futures opened at 5460.4 as against previous close of 5450.2
View Live Blog

Dr Reddys Laboratories SUMMARY

Dr Reddys Laboratories is trading 0.53% upper at Rs 5468.10 as compared to its last closing price. Dr Reddys Laboratories has been trading in the price range of 5525.00 & 5445.00. Dr Reddys Laboratories has given 28.35% in this year & -6.54% in the last 5 days.

 

Dr Reddys Laboratories has TTM P/E ratio 18.14 as compared to the sector P/E of 20.68.There are 38 analysts who have initiated coverage on Dr Reddys Laboratories. There are 9 analysts who have given it a strong buy rating & 10 analysts have given it a buy rating. 8 analysts have given the stock a sell rating.

 

The company posted a net profit of 1405.00 Crores in its last quarter.

 

Listed peers of Dr Reddys Laboratories include Divis Laboratories (0.61%), Cipla (-1.27%), Dr Reddys Laboratories (0.53%) etc.

FAQs about Dr Reddys Laboratories share price

Dr Reddys Laboratories is trading at 5468.10 as on Tue Sep 26 2023 10:13:21. This is 0.53% upper as compared to its previous closing price of 5439.40.

The market capitalization of Dr Reddys Laboratories is 91010.62 Cr as on Tue Sep 26 2023 10:13:21.

The average broker rating on Dr Reddys Laboratories is Hold. The breakup of analyst rating is given below -

  • 9 analysts have given a strong buy rating
  • 10 analysts have given a buy rating
  • 9 analysts have given a hold rating
  • 8 analysts have given a sell rating
  • 3 analysts have given a strong sell rating

The 52 wk high for Dr Reddys Laboratories is 5986.20 whereas the 52 wk low is 4088.70

Dr Reddys Laboratories can be analyzed on the following key metrics -

  • TTM P/E: 18.14
  • Sector P/E: 20.68
  • Dividend Yield: 0.74%
  • D/E ratio: -

Dr Reddys Laboratories reported a net profit of 4507.30 Cr in 2023.

Recommended For You
Trending Stocks
22972.70+327.45(1.45%)
128.85+1.50(1.18%)
1282.10-16.90 (-1.30%)
1423.50-18.55 (-1.29%)